Based on the promoter sequence of BMP2, JASPAR predicted that RUNX1 may be a regulatory transcription factor of BMP2. The regulation of cancer metastasis, angiogenesis, tumor stem cell properties, and resistance to anticancer drugs involves both indirect and direct biological functions of RUNX1 [47]. Here, RUNX1 is linked to neoplasm.